Experimental drug for lung disease fails to reach goal
NCT ID NCT04396366
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study tested an experimental drug called QBW251 in 42 adults with bronchiectasis, a lung condition that causes mucus buildup and infections. The goal was to see if the drug could reduce bacteria in the lungs and improve symptoms like coughing and breathing. However, the study was stopped early, so results are limited.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for BRONCHIECTASIS are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Novartis Investigative Site
Guangzhou, Guangdong, 510120, China
-
Novartis Investigative Site
Shanghai, 200433, China
-
Novartis Investigative Site
Frankfurt, 60596, Germany
-
Novartis Investigative Site
Hanover, 30625, Germany
-
Novartis Investigative Site
Mainz, 55128, Germany
-
Novartis Investigative Site
Barcelona, Catalonia, 08035, Spain
-
Novartis Investigative Site
Girona, Catalonia, 17007, Spain
-
Novartis Investigative Site
Leeds, West Yorkshire, LS9 7TF, United Kingdom
-
Novartis Investigative Site
Cambridge, CB2 0AY, United Kingdom
-
Novartis Investigative Site
Edinburgh, EH10 5HF, United Kingdom
-
Novartis Investigative Site
Liverpool, L7 8XP, United Kingdom
-
Novartis Investigative Site
Liverpool, L9 7AL, United Kingdom
-
Novartis Investigative Site
London, SW3 6PH, United Kingdom
-
Novartis Investigative Site
Manchester, M23 9LT, United Kingdom